AVITA Medical appoints Robert McNamara to board, sets 2023 annual meeting

AVITA Medical, Inc.

Robert McNamara appointed to Board of Directors effective April 1, 2023.
McNamara receives $70K annual cash, $210K initial equity, $105K annual equity (subject to shareholder approval).
McNamara has 25+ years of med-tech leadership; currently on boards of Axonics, Teknova, Xtant Medical.
2023 Annual Meeting scheduled for June 6, 2023 via live audio webcast.

item 5.02 item 8.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Robert McNamara

Board of Directors

RCEL · AVITA Medical, Inc.

Effective: 2023-04-01
Filed: March 27, 2023, 7:59 PM ET

On March 23, 2023, AVITA Medical, Inc. (the “Company”) issued a press release announcing the appointment of Robert McNamara to its Board of Directors (the “Board”), effective April 1, 2023

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Robert McNamara was appointed as Board of Directors at AVITA Medical, Inc..

Action: appointed
Role: Board of Directors

Exact text from the filing

On March 23, 2023, AVITA Medical, Inc. (the “Company”) issued a press release announcing the appointment of Robert McNamara to its Board of Directors (the “Board”), effective April 1, 2023

View on SEC.gov

AVITA Medical, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-23-080474

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.